Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma

Search this Article

Author(s)

    • OGURA Michinori
    • Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital
    • UCHIDA Toshiki
    • Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital
    • ANDO Kiyoshi
    • Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine
    • WATANABE Takashi
    • Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
    • KASAI Masanobu
    • Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital
    • OGAWA Yoshiaki
    • Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine
    • OHMACHI Ken
    • Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine
    • YOKOYAMA Hiroki
    • Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital
    • TOBINAI Kensei
    • Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital

Journal

  • Cancer Sci.

    Cancer Sci. 101(9), 2054-2058, 2010-09-10

References:  23

Cited by:  7

Codes

  • NII Article ID (NAID)
    10027831724
  • NII NACSIS-CAT ID (NCID)
    AA11808050
  • Text Lang
    ENG
  • Article Type
    Journal Article
  • ISSN
    13479032
  • Data Source
    CJP  CJPref 
Page Top